Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
89.81 CHF | -0.63% | -3.71% | +5.82% |
Dec. 06 | Swiss Market Index Ends Week Little Changed; Holcim Shares Down | MT |
Dec. 06 | Novartis Reports 'Positive' Results From Phase 3 Study of Potential Blood Disorder Therapy | MT |
Analyst Opinion | 4m Target Price Revision | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
115.73 | +13.04% | 19 | |||||||
987.86 | +19.49% | 27 | |||||||
938.17 | +19.44% | 23 | |||||||
174.89 | +17.13% | 23 | |||||||
202.88 | +15.15% | 28 | |||||||
130.33 | +26.42% | 25 | |||||||
303.36 | +18.04% | 18 | |||||||
177.04 | +30.37% | 19 | |||||||
328.39 | +20.48% | 26 | |||||||
32.60 | +26.71% | 23 | |||||||
114.09 | +23.77% | 21 | |||||||
60.43 | +1.78% | 21 | |||||||
97.85 | +6.21% | 27 | |||||||
7,416.67 | +10.22% | 15 | |||||||
18.17 | +35.23% | 18 | |||||||
6,338.89 | +35.39% | 18 | |||||||
4,780.29 | +15.94% | 17 | |||||||
59.88 | +20.89% | 17 | |||||||
3.950 | +5.33% | 17 | |||||||
Average | 1,172.71 | +19.00% | 21 | ||||||
Weighted average by Cap. | 712.38 | +19.20% | 23 |
- Stock Market
- Equities
- NOVN Stock
- Sector Novartis AG
- Sector consensus